Sam Brusco, Associate Editor11.29.22
GE Healthcare has begun an agreement with ulrich medical for a GE Healthcare-branded contrast media injector.
The CT motion multi-dose syringeless injector delivers iodinated contrast media for CT procedures. It aims to lower setup time and boost patient throughout via elimination of time-consuming preparation steps, while helping optimize dosing and reduce wasted contrast media.
Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington, showed when compared to a typical dual-syringe based injector using single or multi-dose vials, the CT motion may allow six additional CT exams per day in a busy emergency department. The research analyzed over 6,000 patients who received contrast-enhanced CT or CT angiography and showed CT motion lowers cost from consumables and saves an average of 30 mL of contrast per procedure.
With the syringeless CT motion, the required dose is drawn and injected directly from the injector’s contrast media container, saving time, facilitating the optimal volume of contrast media will be used, reducing wasted leftover contrast, and generating less disposable waste. CT motion also provides injection reports accessible via RIS/PACS for dose management systems and records of prior injections to further optimize dose and improve patient safety.
Marco Campione, Americas GM at GE Healthcare Pharmaceutical Diagnostics told the press: “Radiology departments are focused on managing increasing demand and on conserving contrast media. The CT motion supports efficient operational practices - saving time, saving contrast, saving on consumables, improving workflows and facilitates better patient throughput. We expect demand for iodinated contrast media to double in the next decade, so we are investing, both in production capacity expansion and also in technologies like this that conserve volumes and reduce leftover contrast media.”
Klaus Kiesel, CEO of ulrich medical, said: “We are delighted to be working even more closely with our long-standing partner GE Healthcare, who have already been distributing our injector CT motion in the US market. With GE Healthcare's nationwide brand recognition and great distribution power, we are sure to significantly expand our market share on injectors in the world's largest medical technology market.”
The CT motion multi-dose syringeless injector delivers iodinated contrast media for CT procedures. It aims to lower setup time and boost patient throughout via elimination of time-consuming preparation steps, while helping optimize dosing and reduce wasted contrast media.
Recent research, led by Dushyant Sahani MD, Professor and Chair of Radiology at the University of Washington, showed when compared to a typical dual-syringe based injector using single or multi-dose vials, the CT motion may allow six additional CT exams per day in a busy emergency department. The research analyzed over 6,000 patients who received contrast-enhanced CT or CT angiography and showed CT motion lowers cost from consumables and saves an average of 30 mL of contrast per procedure.
With the syringeless CT motion, the required dose is drawn and injected directly from the injector’s contrast media container, saving time, facilitating the optimal volume of contrast media will be used, reducing wasted leftover contrast, and generating less disposable waste. CT motion also provides injection reports accessible via RIS/PACS for dose management systems and records of prior injections to further optimize dose and improve patient safety.
Marco Campione, Americas GM at GE Healthcare Pharmaceutical Diagnostics told the press: “Radiology departments are focused on managing increasing demand and on conserving contrast media. The CT motion supports efficient operational practices - saving time, saving contrast, saving on consumables, improving workflows and facilitates better patient throughput. We expect demand for iodinated contrast media to double in the next decade, so we are investing, both in production capacity expansion and also in technologies like this that conserve volumes and reduce leftover contrast media.”
Klaus Kiesel, CEO of ulrich medical, said: “We are delighted to be working even more closely with our long-standing partner GE Healthcare, who have already been distributing our injector CT motion in the US market. With GE Healthcare's nationwide brand recognition and great distribution power, we are sure to significantly expand our market share on injectors in the world's largest medical technology market.”